Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT04191018
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Presence of advanced fibrosis or cirrhosis (stage F≥3 METAVIR) based on liver stiffness by transient elastography (≥ 9,5 kPa) or liver biopsy
* Gastrointestinal endoscopy at least 24 months before start of direct-acting agents for HCV treatment
* Liver stiffness measurement at least 18 months after SVR
Exclusion Criteria:
* Autoimmune hepatitis, hepatosplenic schistosomiasis or cholestasis diseases
* Liver transplantation
* Presence of high volume ascites or hepatocellular carcinoma
* Participation in programs of esophageal band ligation for eradication of esophageal varices
* Presence of signs of acute decompensated liver disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT04191018
Study Brief:
Protocol Section:
NCT04191018